To evaluate the potential impact of metyrapone treatment on atherosclerosis susceptibility, we made use of genetically hypercholesterolemic LDL receptor knockout mice that were fed an atherogenic high cholesterol/high fat Western-type diet also containing the farnesoid X receptor (FXR) ligand cholic acid. Here, LDLR is linked to atherosclerosis.